It would be reassuring to find similar results with for example statin therapy in primary prevention setting, statin therapy in patients with diabetes mellitus, or PCSK9 inhibition in patients with familiar hypercholesterolemia. This evidence concerns the gene PCSK9 and familial hypercholesterolemia.